内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-19 · 构建时间： 2026-10-19 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Marpai, Inc.

MRAI · OTC · CIK 0001844392 · Healthcare · Healthcare Plans

内部人信号

40.7 / 100

2 位买方 · 2 条买入交易行 · $3.4K 买入总额

为什么有这个信号？

买方广度较低
买入规模较低
角色中等
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+14.0 / 35
买入规模+0.7 / 25
角色+15.0 / 20
近期性+1.0 / 10
确信度+10.0 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Purchase activity is becoming less recent
  • ✓ 角色得分高 · 买入者中职位最高的是：Chief Financial Officer

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

买方广度与集中度

合资格买方2
买入集中度80%最大买方： EITAN YARON · $2.7K
聚集买入 · 15天2 insiders峰值活动： 2026-05-20–2026-06-02

Roles in the peak window: Chief Financial Officer, Director. Concentration uses priced qualifying P lines only and does not change the saved score.

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Johnson Steve AndrewChief Financial Officer
○●
EITAN YARONDirector
●○
SHIV SAGIVDirector
○
PONS ROBERT MDirector
○
Calabrese Jennifer RosarioDirector
○
Lamendola DamienChief Executive Officer
○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.

信号历史

40.7 / 100

最新留档分数

→ +0.0 pts相对上一个留档快照
  1. 40.8
  2. 40.8
  3. 40.7
  4. 40.7
  5. 40.7

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

5买入
0卖出
17其他 Form 4 交易行
19SEC 申报 · 365天
买入2 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他7 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-12.5%
3M
+389.6%
6M
+1161.5%
12M
+111.6%

波动率与流动性

波动率
155.5%
Beta
—
平均每日成交额
USD 294,565

估值

市值
USD 88.0M
P/E
—

基本面

利润率
-91.5%
ROE
—
细分行业
Healthcare Plans

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, 利润率 · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-13 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
40,389
上期报告
66,965
日均成交量
65,860
回补天数
≤ 1.0

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-06-02Johnson Steve Andrew买入 (P)Class A Common Stock1,100USD 0.62USD 682SEC 申报 ↗
2026-05-20EITAN YARON买入 (P)Class A Common Stock10,000USD 0.27USD 2,700SEC 申报 ↗
2025-11-07SHIV SAGIV买入 (P)Class A Common Stock50,000USD 1.00USD 50,000SEC 申报 ↗
2025-11-07PONS ROBERT M买入 (P)Class A Common Stock50,000USD 1.00USD 50,000SEC 申报 ↗
2025-11-07EITAN YARON买入 (P)Class A Common Stock100,000USD 1.00USD 100,000SEC 申报 ↗
2025-09-30Lamendola Damien买入 (P)Class A Common Stock147,058USD 1.36USD 199,999SEC 申报 ↗
2025-09-10Lamendola Damien买入 (P)Class A Common Stock896,903USD 1.06USD 950,717SEC 申报 ↗
2025-07-29Lamendola Damien买入 (P)Class A Common Stock371,470USD 1.08USD 401,188SEC 申报 ↗
2025-07-17Lamendola Damien买入 (P)Class A Common Stock86,805USD 1.15USD 99,826SEC 申报 ↗
2024-12-05Powers John Paul买入 (P)Class A Common Stock10,000USD 1.13USD 11,300SEC 申报 ↗
2024-12-05Johnson Steve Andrew买入 (P)Class A Common Stock5,000USD 1.13USD 5,650SEC 申报 ↗
2024-12-05EITAN YARON买入 (P)Class A Common Stock110,619USD 1.13USD 124,999SEC 申报 ↗
2024-08-28Lamendola Damien买入 (P)Class A Common Stock1,351,351USD 0.48USD 648,648SEC 申报 ↗
2024-05-29Johnson Steve Andrew买入 (P)Class A Common Stock3,500USD 0.65USD 2,275SEC 申报 ↗
2024-05-28PONS ROBERT M买入 (P)Class A Common Stock5,000USD 0.87USD 4,350SEC 申报 ↗

Form 4 申报证据

22 transaction lines in the latest 365-day window; 113 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-06-02Johnson Steve Andrew买入 (P)Class A Common Stock1,100USD 0.62USD 682SEC 申报 ↗
2026-05-29SHIV SAGIV奖励／授予 (A)Class A Common Stock125,000USD 0.00USD 0SEC 申报 ↗
2026-05-29PONS ROBERT M奖励／授予 (A)Class A Common Stock100,000USD 0.00USD 0SEC 申报 ↗
展开近期 Form 4 证据 (20 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-06-02Johnson Steve Andrew买入 (P)Class A Common Stock1,100USD 0.62USD 682SEC 申报 ↗
2026-05-29SHIV SAGIV奖励／授予 (A)Class A Common Stock125,000USD 0.00USD 0SEC 申报 ↗
2026-05-29PONS ROBERT M奖励／授予 (A)Class A Common Stock100,000USD 0.00USD 0SEC 申报 ↗
2026-05-29Lamendola Damien奖励／授予 (A)Class A Common Stock300,000USD 0.00USD 0SEC 申报 ↗
2026-05-29Johnson Steve Andrew奖励／授予 (A)Class A Common Stock125,000USD 0.00USD 0SEC 申报 ↗
2026-05-29EITAN YARON奖励／授予 (A)Class A Common Stock175,000USD 0.00USD 0SEC 申报 ↗
2026-05-29DiClaudio Colleen奖励／授予 (A)Class A Common Stock125,000USD 0.00USD 0SEC 申报 ↗
2026-05-29Calabrese Jennifer Rosario奖励／授予 (A)Class A Common Stock100,000USD 0.00USD 0SEC 申报 ↗
2026-05-20EITAN YARON买入 (P)Class A Common Stock10,000USD 0.27USD 2,700SEC 申报 ↗
2025-11-07Scrip Dallas奖励／授予 (A)Class A Common Stock100,000USD 1.00USD 100,000SEC 申报 ↗
2025-11-07SHIV SAGIV买入 (P)Class A Common Stock50,000USD 1.00USD 50,000SEC 申报 ↗
2025-11-07PONS ROBERT M买入 (P)Class A Common Stock50,000USD 1.00USD 50,000SEC 申报 ↗
2025-11-07EITAN YARON买入 (P)Class A Common Stock100,000USD 1.00USD 100,000SEC 申报 ↗
2025-10-20SHIV SAGIV奖励／授予 (A)Class A Common Stock75,000USD 0.00USD 0SEC 申报 ↗
2025-10-20PONS ROBERT M奖励／授予 (A)Class A Common Stock225,000USD 0.00USD 0SEC 申报 ↗
2025-10-20Lamendola Damien奖励／授予 (A)Class A Common Stock550,000USD 0.00USD 0SEC 申报 ↗
2025-10-20Johnson Steve Andrew奖励／授予 (A)Class A Common Stock275,000USD 0.00USD 0SEC 申报 ↗
2025-10-20EITAN YARON奖励／授予 (A)Class A Common Stock125,000USD 0.00USD 0SEC 申报 ↗
2025-10-20DiClaudio Colleen奖励／授予 (A)Class A Common Stock75,000USD 0.00USD 0SEC 申报 ↗
2025-10-20Calabrese Jennifer Rosario奖励／授予 (A)Class A Common Stock50,000USD 0.00USD 0SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-19
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码MRAI
CIK0001844392
行业Healthcare
细分行业Healthcare Plans Yahoo Finance
SEC SIC8090 Services-Misc Health & Allied Services, NEC
交易所OTC

数据覆盖

本地 Form 4 历史113 transaction lines from 2021-12-14 to 2026-06-02
60 P purchase lines · 9 S sale lines · 44 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.